The Effect of Teprotumumab on Ocular Surface Symptoms in Thyroid Eye Disease

被引：0
|
作者：
Cale, Mario [1 ]
Osias, Ethan [1 ]
Singh, Pallavi [1 ]
Rootman, Daniel [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Orbital & Ophthalm Plast Surg, Los Angeles, CA 90095 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3997 - A03
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease
    Kossler, Andrea Lora
    Douglas, Raymond
    Dosiou, Chrysoula
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 : S36 - S46
  • [32] Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease"
    Perry, Julian D.
    Hwang, Catherine J.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2025, 41 (01): : 112 - 112
  • [33] Retinal Surface Macrophage Changes in Thyroid Eye Disease before and after Treatment with Teprotumumab
    Otero-Marquez, Oscar
    Fayad, Mona
    Pinhas, Alexander
    Chui, Toco Y. P.
    Rosen, Richard B. B.
    Reddy, Harsha S. S.
    CASE REPORTS IN OPHTHALMOLOGICAL MEDICINE, 2022, 2022
  • [34] Ocular surface disease in thyroid eye disease: A narrative review
    Rana, Harkaran S. S.
    Akella, Sruti S. S.
    Clabeaux, Carson E. E.
    Skurski, Zachary P. P.
    Aakalu, Vinay K. K.
    OCULAR SURFACE, 2022, 24 : 67 - 73
  • [35] Stability of Ocular Alignment After Teprotumumab Therapy in a Cohort of Patients With Thyroid Eye Disease and Baseline Diplopia
    Davis, James B.
    Mudalegundi, Shwetha
    Henderson, Amanda D.
    Carey, Andrew R.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2024, 44 (04) : 527 - 532
  • [36] Teprotumumab for the treatment of thyroid eye disease: The Holy grail, really?
    Martel, A.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2023, 46 (06): : 567 - 570
  • [37] The role of teprotumumab in chronic, clinically active thyroid eye disease
    Yu, Caroline Y.
    Simmons, Brittany A.
    Pham, Chau M.
    Shriver, Erin M.
    EYE, 2022, 36 (07) : 1500 - 1501
  • [38] Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease
    Rosenblatt, Tatiana R.
    Chiou, Carolina A.
    Yoon, Michael K.
    Wolkow, Natalie
    Lee, Nahyoung Grace
    Freitag, Suzanne K.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (02): : 187 - 191
  • [39] Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab
    Ho, Tiffany C.
    Maamari, Robi N.
    Kossler, Andrea L.
    Sears, Connie M.
    Freitag, Suzanne K.
    Reshef, Edith R.
    Shinder, Roman
    Rootman, Daniel B.
    Diniz, Stefania B.
    Kahana, Alon
    Schlachter, Dianne
    Do, Thai H.
    Kally, Peter
    Turner, Sara
    Mokhtarzadeh, Ali
    Harrison, Andrew R.
    Hwang, Christopher J.
    Kim, Hee Joon
    Avila, Sarah A.
    Thomas, Dilip A.
    Magazin, Maja
    Wester, Sara T.
    Lee, Wendy W.
    Clauss, Kevin D.
    Holds, John B.
    Sniegowski, Matthew
    Compton, Christopher J.
    Briggs, Christian
    Malik, Amina I.
    Lucarelli, Mark J.
    Burkat, Cat N.
    Patel, Luv G.
    Couch, Steven M.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2023, 39 (02): : 150 - 155
  • [40] Refractory Thyroid Eye Disease Unresponsive to Teprotumumab: A Case Report
    Singh, Gurdeep
    Taylor, Brittany
    Michalek, Samantha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
12345